XFRA CAPITAL ADJUSTMENT INFORMATION

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument 9HJ SE0018040784 CINIS FERTILIZER AB EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument 9HJ SE0018040784 CINIS FERTILIZER AB EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument PGO0 SE0023261532 PROSTATYPE GENOMICS AB EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument PGO0 SE0023261532 PROSTATYPE GENOMICS AB EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument 76D FR0010844464 MEDESIS PHARMA IL EO 2,- EQUITY wird ex Kapitalmassnahme gehandelt am 15.05.2025
The instrument 76D FR0010844464 MEDESIS PHARMA IL EO 2,- EQUITY is traded ex capital adjustment on 15.05.2025

Das Instrument 9H0 FI4000233317 ENERSIZE OYJ EQUITY wird ex Kapitalmassnahme gehandelt am 15.05.2025
The instrument 9H0 FI4000233317 ENERSIZE OYJ EQUITY is traded ex capital adjustment on 15.05.2025

Das Instrument E2Z ES0157097017 ALMIRALL S.A. EO -,12 EQUITY wird ex Kapitalmassnahme gehandelt am 15.05.2025
The instrument E2Z ES0157097017 ALMIRALL S.A. EO -,12 EQUITY is traded ex capital adjustment on 15.05.2025

Das Instrument Z0Y US46982L1089 JACOBS SOLUTIONS INC. DL1 EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument Z0Y US46982L1089 JACOBS SOLUTIONS INC. DL1 EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument DEVL SG1L01001701 DBS GRP HLDGS SD 1 EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument DEVL SG1L01001701 DBS GRP HLDGS SD 1 EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument AF8 NO0003078107 AF GRUPPEN ASA A NK 0,05 EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument AF8 NO0003078107 AF GRUPPEN ASA A NK 0,05 EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Das Instrument MX7A HK0200030994 MELCO INTL SUBDIV. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025
The instrument MX7A HK0200030994 MELCO INTL SUBDIV. EQUITY is traded cum capital adjustment on 15.05.2025 and ex capital adjustment on 16.05.2025

Zeit	Aktuelle Nachrichten
Mi	AF Gruppen ASA: Building apartments in Drammen
Di	AF Gruppen ASA: Share capital increase completed
Mo	AF Gruppen ASA: Expanding transformer stations in Bamble and Kvinesdal
Mo	AF Gruppen ASA: Constructing office building in Larvik
21.10.	AF Gruppen ASA: Building apartments in Hamar

Zeit

Aktuelle Nachrichten

AF Gruppen ASA: Building apartments in Drammen

AF Gruppen ASA: Share capital increase completed

AF Gruppen ASA: Expanding transformer stations in Bamble and Kvinesdal

AF Gruppen ASA: Constructing office building in Larvik

21.10.

AF Gruppen ASA: Building apartments in Hamar

Zeit	Aktuelle Nachrichten
14.10.	Almirall H1 2025 presentation: European dermatology drives 12.7% revenue growth
14.10.	Stifel initiates Almirall stock with Buy rating on dermatology growth
29.09.	Neither Grifols, Rovi nor Almirall to be significantly affected by tariffs on pharmaceutical sector
18.09.	Almirall, S.A.: Almirall Presents Long-Term Results from First Real-World Dermatology Study Using WHO-5 Well-Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 2025	Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults... ► Artikel lesen
17.09.	Almirall, S.A.: EADV 2025: Almirall Advances Skin Science and Leads Innovation for Holistic Patient Care in Medical Dermatology	Almirall's scientific presence at the 34th EADV congress reflects its broad portfolio of dermatological treatments and patient-centric approach featuring 44 abstracts, two expert-led symposia... ► Artikel lesen

Zeit

Aktuelle Nachrichten

14.10.

Almirall H1 2025 presentation: European dermatology drives 12.7% revenue growth

14.10.

Stifel initiates Almirall stock with Buy rating on dermatology growth

29.09.

Neither Grifols, Rovi nor Almirall to be significantly affected by tariffs on pharmaceutical sector

18.09.

Almirall, S.A.: Almirall Presents Long-Term Results from First Real-World Dermatology Study Using WHO-5 Well-Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 2025

Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults...
► Artikel lesen

17.09.

Almirall, S.A.: EADV 2025: Almirall Advances Skin Science and Leads Innovation for Holistic Patient Care in Medical Dermatology

Almirall's scientific presence at the 34th EADV congress reflects its broad portfolio of dermatological treatments and patient-centric approach featuring 44 abstracts, two expert-led symposia...
► Artikel lesen

Zeit	Aktuelle Nachrichten
09.10.	Cinis Fertilizer AB: Cinis Fertilizer removes operational goal and initiates strategic review	The board and management of Cinis Fertilizer have decided to remove current target of reaching the production rate of 100,000 tons of potassium sulfate by the end of the year. The decision is made after... ► Artikel lesen
11.09.	Cinis Fertilizer AB: Cinis Fertilizer increases its production of environmentally friendly mineral fertilizer	During August 2025, Cinis Fertilizer produced approximately 5.5 thousand tons of water-soluble potassium sulfate at its plant in Köpmanholmen outside Örnsköldsvik, Sweden. The production volume of mineral... ► Artikel lesen
21.08.	Cinis Fertilizer AB: Interim report for the period January 1 - June 30, 2025	Focus on increasing profitability With financing secured and increased production in the second quarter, Cinis Fertilizer will focus on further increasing its profitability. This includes driving actions... ► Artikel lesen
28.07.	Cinis Fertilizer AB: Cinis delivers 4,900 tons of potassium sulfate	Cinis Fertilizer has shipped full cargo of water-soluble potassium sulfate from the production facility in Örnsköldsvik, Sweden, to its customer Van Iperen International in the Netherlands. The cargo... ► Artikel lesen
30.06.	Cinis Fertilizer AB: Cinis delivers an additional 4,600 tons of potassium sulfate	Cinis Fertilizer has sent another shipload of water-soluble potassium sulfate to its customer Van Iperen International. The cargo amounts to approximately 4,600 tons. The next shipload of water-soluble... ► Artikel lesen

Zeit

Aktuelle Nachrichten

09.10.

Cinis Fertilizer AB: Cinis Fertilizer removes operational goal and initiates strategic review

The board and management of Cinis Fertilizer have decided to remove current target of reaching the production rate of 100,000 tons of potassium sulfate by the end of the year. The decision is made after...
► Artikel lesen

11.09.

Cinis Fertilizer AB: Cinis Fertilizer increases its production of environmentally friendly mineral fertilizer

During August 2025, Cinis Fertilizer produced approximately 5.5 thousand tons of water-soluble potassium sulfate at its plant in Köpmanholmen outside Örnsköldsvik, Sweden. The production volume of mineral...
► Artikel lesen

21.08.

Cinis Fertilizer AB: Interim report for the period January 1 - June 30, 2025

Focus on increasing profitability With financing secured and increased production in the second quarter, Cinis Fertilizer will focus on further increasing its profitability. This includes driving actions...
► Artikel lesen

28.07.

Cinis Fertilizer AB: Cinis delivers 4,900 tons of potassium sulfate

Cinis Fertilizer has shipped full cargo of water-soluble potassium sulfate from the production facility in Örnsköldsvik, Sweden, to its customer Van Iperen International in the Netherlands. The cargo...
► Artikel lesen

30.06.

Cinis Fertilizer AB: Cinis delivers an additional 4,600 tons of potassium sulfate

Cinis Fertilizer has sent another shipload of water-soluble potassium sulfate to its customer Van Iperen International. The cargo amounts to approximately 4,600 tons. The next shipload of water-soluble...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Do	DBS and Goldman Sachs complete first interbank OTC crypto options trade
Mi	DBS and Goldman Sachs Achieve Milestone in Digital Asset Evolution
Mi	DBS Foundation launches two flagship aging programs
23.10.	DBS Teams Up With Mastercard: When Banking Meets Gaming
23.10.	DBS GROUP HOLDINGS LTD: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::NOTIFICATION OF RESULTS RELEASE

Zeit

Aktuelle Nachrichten

DBS and Goldman Sachs complete first interbank OTC crypto options trade

DBS and Goldman Sachs Achieve Milestone in Digital Asset Evolution

DBS Foundation launches two flagship aging programs

23.10.

DBS Teams Up With Mastercard: When Banking Meets Gaming

23.10.

DBS GROUP HOLDINGS LTD: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::NOTIFICATION OF RESULTS RELEASE

Zeit	Aktuelle Nachrichten
Mo	Enersize Oyj: Enersize receives new call-off for service and maintenance of LSP steam equipment from global industrial company	Enersize has received a new call-off order from a global industrial company operating in the process industry. The assignment covers service and maintenance of Low Steam Pressure (LSP) equipment and... ► Artikel lesen
21.10.	Enersize Oyj: Enersize strengthens its position in the pharmaceutical industry - awarded renewed trust for energy efficiency in steam and compressed air systems	Following documented results in a previous assignment, Enersize has been awarded renewed trust by a leading pharmaceutical company to continue optimizing energy use in both steam and compressed air... ► Artikel lesen
13.10.	The observation status for Enersize Oyj is updated	On November 28, 2023, the financial instruments in Enersize Oyj (the "Company") were given observation status with reference to uncertainty in respect of the Company's financial position. On... ► Artikel lesen
13.10.	Enersize Oyj: Enersize and Pure Positioning AB decide to discontinue the acquisition process under the previous Letter of Intent	Enersize Oyj ("Enersize" or the "Company") and Pure Positioning AB (publ) ("Pure") announce that the parties have jointly decided to discontinue the acquisition process under the previously signed Letter... ► Artikel lesen
03.10.	Enersize Oyj: Enersize and Pure Positioning AB agree on commercial terms for acquisition - transaction concluded at a premium price	Enersize Oyj ("Enersize" or the "Company") and Pure Positioning AB (publ) ("PPAB") have today signed an addendum to the previously announced Letter of Intent ("LOI"), originally disclosed on 1 September... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Enersize Oyj: Enersize receives new call-off for service and maintenance of LSP steam equipment from global industrial company

Enersize has received a new call-off order from a global industrial company operating in the process industry. The assignment covers service and maintenance of Low Steam Pressure (LSP) equipment and...
► Artikel lesen

21.10.

Enersize Oyj: Enersize strengthens its position in the pharmaceutical industry - awarded renewed trust for energy efficiency in steam and compressed air systems

Following documented results in a previous assignment, Enersize has been awarded renewed trust by a leading pharmaceutical company to continue optimizing energy use in both steam and compressed air...
► Artikel lesen

13.10.

The observation status for Enersize Oyj is updated

On November 28, 2023, the financial instruments in Enersize Oyj (the "Company") were given observation status with reference to uncertainty in respect of the Company's financial position. On...
► Artikel lesen

13.10.

Enersize Oyj: Enersize and Pure Positioning AB decide to discontinue the acquisition process under the previous Letter of Intent

Enersize Oyj ("Enersize" or the "Company") and Pure Positioning AB (publ) ("Pure") announce that the parties have jointly decided to discontinue the acquisition process under the previously signed Letter...
► Artikel lesen

03.10.

Enersize Oyj: Enersize and Pure Positioning AB agree on commercial terms for acquisition - transaction concluded at a premium price

Enersize Oyj ("Enersize" or the "Company") and Pure Positioning AB (publ) ("PPAB") have today signed an addendum to the previously announced Letter of Intent ("LOI"), originally disclosed on 1 September...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Di	Jacobs wins EirGrid framework to drive energy transition
Mo	Jacobs Solutions' Quarterly Earnings Preview: What You Need to Know
24.10.	Jacobs Solutions seesaws amid takeover speculation
23.10.	Jacobs receives 5-year contract extension for Alaska port modernization
23.10.	Jacobs expands role in strengthening Alaska's maritime hub

Zeit

Aktuelle Nachrichten

Jacobs wins EirGrid framework to drive energy transition

Jacobs Solutions' Quarterly Earnings Preview: What You Need to Know

24.10.

Jacobs Solutions seesaws amid takeover speculation

23.10.

Jacobs receives 5-year contract extension for Alaska port modernization

23.10.

Jacobs expands role in strengthening Alaska's maritime hub

Zeit	Aktuelle Nachrichten
15.05.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2025		The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2025.ISIN NameCA05259R1073 AUSTRALIS... ► Artikel lesen
15.05.	XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025		Das Instrument B8D CH1107979838 R+S GROUP HOLDI CUM.PREF. EQUITY wird cum Kapitalmassnahme gehandelt am 15.05.2025 und ex Kapitalmassnahme am 16.05.2025 The instrument B8D CH1107979838 R+S GROUP HOLDI... ► Artikel lesen

Zeit

Aktuelle Nachrichten

15.05.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2025

The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2025.ISIN NameCA05259R1073 AUSTRALIS...
► Artikel lesen

15.05.

XFRA CAPITAL ADJUSTMENT INFORMATION - 15.05.2025

Zeit	Aktuelle Nachrichten
25.09.	MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REPLY FORM TO NEW REGISTERED SHAREHOLDERS
25.09.	MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS
25.09.	MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REQUEST FORM TO EXISTING REGISTERED SHAREHOLDERS
25.09.	MELCO INT'L DEV (00200): 2025 INTERIM REPORT
16.09.	MELCO INT'L DEV (00200): ANNOUNCEMENT - CONTINUING CONNECTED TRANSACTIONS

Zeit

Aktuelle Nachrichten

25.09.

MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REPLY FORM TO NEW REGISTERED SHAREHOLDERS

25.09.

MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS

25.09.

MELCO INT'L DEV (00200): NOTIFICATION LETTER AND REQUEST FORM TO EXISTING REGISTERED SHAREHOLDERS

25.09.

MELCO INT'L DEV (00200): 2025 INTERIM REPORT

16.09.

MELCO INT'L DEV (00200): ANNOUNCEMENT - CONTINUING CONNECTED TRANSACTIONS

Zeit	Aktuelle Nachrichten
26.08.	Prostatype Genomics AB: Prostatype Genomics reaches important commercial breakthrough by initiating billing for Prostatype to insurance companies in the USA	Prostatype Genomics AB ("Prostatype Genomics" or the "Company") has reached an important commercial milestone in the USA by immediately starting to bill Prostatype® to several insurance companies. Prostatype®... ► Artikel lesen
23.07.	Prostatype Genomics AB: Prostatype Genomics publishes its interim report for the first half of 2025	Prostatype Genomics AB today publishes its interim report for the first half of 2025. The full interim report is attached and can also be downloaded from the company's website, www.prostatypegenomics.com. First... ► Artikel lesen
22.07.	Prostatype Genomics AB: Positive results for Prostatype confirmed in published Spanish multicentre study	Prostatype Genomics announces that previously communicated positive results from a Spanish multicentre study with Prostatype®, have now been confirmed in a scientific journal. The study included 93... ► Artikel lesen
03.06.	Prostatype Genomics AB: Strong results for Prostatype in published Taiwan study - creating opportunities for commercial expansion in Asia	Prostatype Genomics announces that strong results from a study in Taiwan with the company's prognostic genomic test Prostatype® have now been published in the scientific journal BJUI Compass. In the... ► Artikel lesen
15.05.	Prostatype Genomics AB: Prostatype Genomics updates on commercial progress in the U.S.	Prostatype Genomics announces that the company's commercial activities in the U.S. continue to develop in a positive way. The number of selected American urologists at urology clinics/hospitals who... ► Artikel lesen

Zeit

Aktuelle Nachrichten

26.08.

Prostatype Genomics AB: Prostatype Genomics reaches important commercial breakthrough by initiating billing for Prostatype to insurance companies in the USA

Prostatype Genomics AB ("Prostatype Genomics" or the "Company") has reached an important commercial milestone in the USA by immediately starting to bill Prostatype® to several insurance companies. Prostatype®...
► Artikel lesen

23.07.

Prostatype Genomics AB: Prostatype Genomics publishes its interim report for the first half of 2025

Prostatype Genomics AB today publishes its interim report for the first half of 2025. The full interim report is attached and can also be downloaded from the company's website, www.prostatypegenomics.com. First...
► Artikel lesen

22.07.

Prostatype Genomics AB: Positive results for Prostatype confirmed in published Spanish multicentre study

Prostatype Genomics announces that previously communicated positive results from a Spanish multicentre study with Prostatype®, have now been confirmed in a scientific journal. The study included 93...
► Artikel lesen

03.06.

Prostatype Genomics AB: Strong results for Prostatype in published Taiwan study - creating opportunities for commercial expansion in Asia

Prostatype Genomics announces that strong results from a study in Taiwan with the company's prognostic genomic test Prostatype® have now been published in the scientific journal BJUI Compass. In the...
► Artikel lesen

15.05.

Prostatype Genomics AB: Prostatype Genomics updates on commercial progress in the U.S.

Prostatype Genomics announces that the company's commercial activities in the U.S. continue to develop in a positive way. The number of selected American urologists at urology clinics/hospitals who...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Di	Berenberg initiates R&S Group stock with Buy rating on transformer demand
Di	Berenberg startet Coverage für R&S Group mit "Buy" - Transformator-Nachfrage als Treiber
11.09.	R&S Group meldet starkes Q2-Wachstum 2025 und treibt Expansion in Europa voran
11.09.	R&S Group H1 2025 slides reveal 88% revenue surge as new CEO outlines strategy
11.09.	R&S Group hat Halbjahres-Gewinn mehr als verdoppelt	Sissach - Der Baselbieter Trafohersteller R&S hat im ersten Halbjahr 2025 den Gewinn mehr als verdoppelt. Das Unternehmen übertraf dabei die Erwartung der Analysten. Die Profitabilität ging wie angekündigt... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Berenberg initiates R&S Group stock with Buy rating on transformer demand

Berenberg startet Coverage für R&S Group mit "Buy" - Transformator-Nachfrage als Treiber

11.09.

R&S Group meldet starkes Q2-Wachstum 2025 und treibt Expansion in Europa voran

11.09.

R&S Group H1 2025 slides reveal 88% revenue surge as new CEO outlines strategy

11.09.

R&S Group hat Halbjahres-Gewinn mehr als verdoppelt

Sissach - Der Baselbieter Trafohersteller R&S hat im ersten Halbjahr 2025 den Gewinn mehr als verdoppelt. Das Unternehmen übertraf dabei die Erwartung der Analysten. Die Profitabilität ging wie angekündigt...
► Artikel lesen

Unternehmen / Aktien	Kurs	%
AF GRUPPEN ASA	14,720	-0,41 %
ALMIRALL SA	12,540	-1,10 %
CINIS FERTILIZER AB	0,017	+3,70 %
DBS GROUP HOLDINGS LTD	36,100	+0,39 %
ENERSIZE OYJ	0,000	0,00 %
JACOBS SOLUTIONS INC	138,00	+0,73 %
MEDESIS PHARMA SA	0,290	0,00 %
MELCO INTERNATIONAL DEVELOPMENT LTD	0,540	0,00 %
PROSTATYPE GENOMICS AB	0,040	-2,91 %
R&S GROUP HOLDING AG	29,310	+0,64 %

Unternehmen / Aktien

Kurs

AF GRUPPEN ASA

14,720

-0,41 %

ALMIRALL SA

12,540

-1,10 %

CINIS FERTILIZER AB

0,017

+3,70 %

DBS GROUP HOLDINGS LTD